Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

New-Tech "Grace Period" Among Industry Recommendations For ACOs

This article was originally published in The Gray Sheet

Executive Summary

AdvaMed says it wants CMS to permit at least a five-year grace period from accountable care organization payment rules for physician early adopters of new medical technologies and treatments.

You may also be interested in...



Device Industry Urges CMS To Protect Use Of Medical Innovations In ACO Program

In an attempt to prevent accountable care organizations from stifling medtech innovation, medical device groups are calling for widespread changes to a Medicare Shared Savings Program proposal unveiled earlier this spring.

Device Industry Urges CMS To Protect Use Of Medical Innovations In ACO Program

In an attempt to prevent accountable care organizations from stifling medtech innovation, medical device groups are calling for widespread changes to a Medicare Shared Savings Program proposal unveiled earlier this spring.

AdvaMed Urges A Different Approach To User Fee Performance Goals

AdvaMed says it wants FDA to set new user fee performance goals that better reflect the total time it takes to get a product through FDA and onto the market.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT029676

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel